The Johns Hopkins Center for Psychedelic and Consciousness Research is one of the world’s leading institutions dedicated to studying psychedelic substances and their potential applications in medicine and human well-being. Its core mission is to advance scientific understanding of psychedelics—such as psilocybin—and explore how they may be used to treat mental health disorders, improve overall well-being, and deepen insights into consciousness. The center emphasizes rigorous, ethically conducted clinical trials and interdisciplinary collaboration, aiming to generate evidence-based knowledge that can inform both clinical practice and public understanding.
Building on a resurgence of research that began in the early 2000s, the center has produced more than 150 peer-reviewed studies and is widely considered a global leader in the field. Its research spans conditions such as depression, addiction, PTSD, and existential distress, while also investigating how psychedelics affect brain function and subjective experience. In addition to research, the center prioritizes education—training clinicians, informing the public, and preparing the next generation of scientists—while maintaining a strong focus on safety, ethics, and balanced evaluation of both the risks and benefits of psychedelic therapies.
Click here to learn more about Johns Hopkins Center for Psychedelic and Consciousness Research.